🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase II trial tests whether ruxolitinib works to shrink tumors in pat...
Status
Recruiting
Location
Dana-Farber Cancer Institute
Start Date
2023-05-03
Trial ID
NCT05592015
Treatments Being Tested
This phase I/II trial studies the side effects and best dose of ruxolitinib...
Status
Terminated
Location
M D Anderson Cancer Center
Start Date
2013-07-24
Trial ID
NCT01751425
Treatments Being Tested
During SARS-Cov2 infection with serious respiratory implication and high sy...
Status
Terminated
Location
AP-HM, Hôpital de la Conception
Start Date
2020-08-19
Trial ID
NCT04366232
Treatments Being Tested
This phase II trial studies how well ruxolitinib works in treating patients...
Status
Recruiting
Location
Stanford Cancer Institute Palo Alto
Start Date
2019-11-15
Trial ID
NCT03801434
Treatments Being Tested
This phase I trial studies the side effects and best dose of ruxolitinib wh...
Status
Recruiting
Location
Ohio State University Comprehensive Cancer Center
Start Date
2019-08-16
Trial ID
NCT03874052
Currently, the principal strategy for immune checkpoint inhibitors (ICI)-re...
Status
Recruiting
Location
Quzhou people's hospital
Start Date
2024-12-31
Trial ID
NCT06715982
Treatments Being Tested
Currently, the principal strategy for immune checkpoint inhibitors (ICI)-re...
Status
Not Yet Recruiting
Location
Quzhou people's hospital
Start Date
2026-03-25
Trial ID
NCT07530224
Treatments Being Tested
Steroid-refractory acute GVHD (srGVHD) is one of the causes of mortality af...
Status
Completed
Location
First Pavlov State Medical University of St. Petersburg
Start Date
2016-08
Trial ID
NCT02997280
Treatments Being Tested
This study evaluates KRT-232, a novel oral small molecule inhibitor of MDM2...
Status
Unknown
Location
The Kirklin Clinic of UAB Hospital
Start Date
2019-01-15
Trial ID
NCT03662126
Treatments Being Tested
This phase I trial studies how well biomarker-guided ruxolitinib works for ...
Status
Recruiting
Location
City of Hope Medical Center
Start Date
2026-04-29
Trial ID
NCT07025538
Treatments Being Tested